2011
DOI: 10.30843/nzpp.2011.64.5972
|View full text |Cite
|
Sign up to set email alerts
|

Succinate dehydrogenase inhibitor (SDHI) fungicide resistance prevention strategy

Abstract: Succinate dehydrogenase inhibitor (SDHI) fungicides are currently represented in New Zealand by eight active ingredients bixafen boscalid carboxin fluaxapyroxad fluopyram isopyrazam penthiopyrad and sedaxane They are either currently registered or undergoing development in New Zealand for use against a range of ascomycete and basiodiomycete pathogens in crops including cereals ryegrass seed apples pears grapes stonefruit cucurbits and kiwifruit These fungicides are considered to have medium to high risk of res… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
12
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 11 publications
0
12
0
Order By: Relevance
“…Inhibition of fungal respiration by binding to the ubiquinone-binding site in the complex II of mitochondria [58] Carboxin, benodanil, flutolanil, fenfuran, fluxapryroxad, fluxypyram, thifluzamide, furametpyr [59] Botrytis cinerea, Alternaria alternate, Didymella brioniae, Podosphaeera xanthii, Corynespora cassiicola [60][61][62][63] Mutations in succinate dehydrogenase gene (amino acid substitution H257L or H257Y) [58,62] Anilinopyrimidine Inhibition of methionine synthesis and secretion of hydrolytic enzymes [64] Cyprodinil, mepanipyrim and pyrimethanil [65] Botrytis cinerea, Venturia inaequalis, Oculimacula spp. [66][67][68] This mechanism is not completely clear; it has been suggested to involve the overproduction of ABC (ATP-binding cassette) transporters or the modification of the target sites [69] Qo inhibitor Blocks fungal energy production through inhibition of mitochondrial respiration by binding to the Qo site of complex III [70] Azoxystrobin, mandestrobin, pyraclostrobin, kresoxim-methyl, dimoxystrobin, famoxadone, fluoxastrobin, fenamidone, pyribencarb [65] Erysiphe necator, Pseudopernospora cubensis, Venturia inaequalis, Alternaria solani, Pyrenophora teres, Pythium aphanidermatum, Pyrenophora tritici-repentis [65] Point mutations in the mitochondrial cytochrome b (cyt b) gene (G143A, F129L, G137R) [57,70] Morpholine Inhibition of ergosterol synthesis by blocking ∆14-reductase and ∆8-∆7-isomerase [6] Aldomorph, fenpropimorph, dodemorph, tridemorph [65] Decreased sensitivity in powdery mildews [16] Unknown [16] Azole Suppression of ergosterol synthesis by inhibiting 14α-demethylase [12] Imazalil, oxpoconazole, triflumizole, diniconazole, epoxiconazole, flutriafol [65] Zymoseptoria tritici, Venturia inaequalis, Penicillium digitatum, Cercospora beticola, Monilinia fructicola, Brumeriela jaapii, Botrytis cinérea, Penicillium digitatum, Zymoseptoria tritici [71,72] Mutations in cyp51, upregulation of cyp51 and the genes encoding membrane transporters [72] 2.2.1.…”
Section: Succinate Dehydrogenase Inhibitormentioning
confidence: 99%
See 3 more Smart Citations
“…Inhibition of fungal respiration by binding to the ubiquinone-binding site in the complex II of mitochondria [58] Carboxin, benodanil, flutolanil, fenfuran, fluxapryroxad, fluxypyram, thifluzamide, furametpyr [59] Botrytis cinerea, Alternaria alternate, Didymella brioniae, Podosphaeera xanthii, Corynespora cassiicola [60][61][62][63] Mutations in succinate dehydrogenase gene (amino acid substitution H257L or H257Y) [58,62] Anilinopyrimidine Inhibition of methionine synthesis and secretion of hydrolytic enzymes [64] Cyprodinil, mepanipyrim and pyrimethanil [65] Botrytis cinerea, Venturia inaequalis, Oculimacula spp. [66][67][68] This mechanism is not completely clear; it has been suggested to involve the overproduction of ABC (ATP-binding cassette) transporters or the modification of the target sites [69] Qo inhibitor Blocks fungal energy production through inhibition of mitochondrial respiration by binding to the Qo site of complex III [70] Azoxystrobin, mandestrobin, pyraclostrobin, kresoxim-methyl, dimoxystrobin, famoxadone, fluoxastrobin, fenamidone, pyribencarb [65] Erysiphe necator, Pseudopernospora cubensis, Venturia inaequalis, Alternaria solani, Pyrenophora teres, Pythium aphanidermatum, Pyrenophora tritici-repentis [65] Point mutations in the mitochondrial cytochrome b (cyt b) gene (G143A, F129L, G137R) [57,70] Morpholine Inhibition of ergosterol synthesis by blocking ∆14-reductase and ∆8-∆7-isomerase [6] Aldomorph, fenpropimorph, dodemorph, tridemorph [65] Decreased sensitivity in powdery mildews [16] Unknown [16] Azole Suppression of ergosterol synthesis by inhibiting 14α-demethylase [12] Imazalil, oxpoconazole, triflumizole, diniconazole, epoxiconazole, flutriafol [65] Zymoseptoria tritici, Venturia inaequalis, Penicillium digitatum, Cercospora beticola, Monilinia fructicola, Brumeriela jaapii, Botrytis cinérea, Penicillium digitatum, Zymoseptoria tritici [71,72] Mutations in cyp51, upregulation of cyp51 and the genes encoding membrane transporters [72] 2.2.1.…”
Section: Succinate Dehydrogenase Inhibitormentioning
confidence: 99%
“…It was introduced into the market in 1966 [59] and targets basidiomycete pathogens [21]. Generation II SDHIs, including boscalid, fluxapryroxad, and fluxypyram, exhibit high antifungal activity in cereals, fruit trees, vegetables, and field crops [62]. This class of antifungals inhibits fungal respiration by blocking the ubiquinone-binding site (Q-site) in complex II of mitochondria [61].…”
Section: Succinate Dehydrogenase Inhibitor (Sdhi)mentioning
confidence: 99%
See 2 more Smart Citations
“…In accordance with the recommendations of FRAC, due to the presence of cross-resistance within the SDHI group, the preparations should be used prophylactically if the risk of the disease is high. They should not be used in emergency, particularly when the pathogen population is large (McKay et al 2011). These preparations should be used up to 2 times during the growing season best in combination with another active ingredient, or alternatively with substances from other groups that do not exhibit cross-resistance (McKay et al 2011).…”
Section: Pyridinecarboxamide Inhibitors Of Succinate Dehydrogenase (Smentioning
confidence: 99%